HospiFlow: Intrahospital Transport in Patients With High-flow Nasal Oxygenation: Prospective Observational Study
Study Details
Study Description
Brief Summary
High-flow nasal oxygen therapy is commonly used in intensive care unit (ICU). Intra-hospital transfer of critical patients is frequent: 1) to perform diagnostic 2) between emergency room or medical wards and ICU. During theses transfers, oxygenation should be continued.
There is high-flow nasal oxygen therapy for transport using an external battery. This mode of operation in transport mode allows about 30-45 min of autonomy.
Intra-hospital transport under high-flow nasal oxygen therapy has been previously described on children.
The objective of this study is to evaluate the occurrence of complications during intra-hospital transports under high-flow nasal oxygen of critical patients.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Outcome Measures
Primary Outcome Measures
- Incidence of severe adverse events during intra-hospital transport [Up to 28 days]
To evaluate the incidence of severe adverse events during intra-hospital transport of patients treated with high-flow nasal oxygen surpervised by an ICU staff. Severe adverse event is defined by the occurrence of intubation during transport or severe hypoxemia defined as pulse oxygen saturation (SpO2 < 80%) or cardiorespiratory arrest.
Secondary Outcome Measures
- Incidence of minor adverse events during intra-hospital transport [Up to 28 days]
To evaluate the incidence of minor adverse events during intra-hospital transport of patients treated with high-flow nasal oxygen surpervised by an ICU staff. Minor adverse event is defined by the occurrence of the need to increase the FiO2 or a pull-out of nasal cannulas or the use of an alternative mode of oxygenation (standard oxygen or noninvasive ventilation) or a failure of high-flow nasal oxygenation system (ie battery failure)
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patient treated with high-flow nasal oxygen therapy before the intra-hospital transport prior to transport
-
Requiring an intra-hospital transport (e.g., CT scan, OR, etc.) or inter-departmental transport supervised by the ICU team
Nb: Once the patient is included in the study, any intra-hospital transport under high-flow nasal oxygen therapy will be analyzed until discharge from the intensive care unit and at until D28.
Exclusion Criteria:
-
Under 18 years old
-
Patient being under guardianship, tutorship or curatorship
-
Pregnancy or breastfeeding
-
Lack of social security number
-
Refusal to participate in the study
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Hospital Center of DAX | DAX | France | ||
| 2 | CH de Martigues | Martigues | France | ||
| 3 | CHR d'ORLEANS | Orléans | France | ||
| 4 | CH Bretagne Atlantique vannes-Auray | Vannes | France | 56017 |
Sponsors and Collaborators
- Centre Hospitalier Régional d'Orléans
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- CHRO-2022-01